🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| 14/12/2022 | 0,7300 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 15/03/2018 | 52,43 | 53,18 | 52,38 | 52,72 | +0,82% | 1,53% | 10.560.277 |
| 14/03/2018 | 52,74 | 52,89 | 51,82 | 52,29 | -1,03% | 2,03% | 11.692.222 |
| 13/03/2018 | 53,19 | 53,20 | 52,48 | 52,83 | +0,02% | 1,35% | 12.272.080 |
| 12/03/2018 | 53,18 | 53,56 | 52,71 | 52,82 | +0,40% | 1,60% | 11.269.039 |
| 09/03/2018 | 52,51 | 52,66 | 52,19 | 52,61 | +0,69% | 0,89% | 9.240.006 |
| 08/03/2018 | 52,02 | 52,31 | 51,87 | 52,25 | +0,53% | 0,84% | 7.705.001 |
| 07/03/2018 | 51,37 | 52,08 | 51,29 | 51,98 | +0,31% | 1,54% | 12.817.564 |
| 06/03/2018 | 51,99 | 52,20 | 51,36 | 51,81 | -0,18% | 1,63% | 9.716.951 |
| 05/03/2018 | 51,76 | 52,20 | 51,60 | 51,91 | +0,07% | 1,16% | 13.743.577 |
| 02/03/2018 | 51,03 | 51,94 | 50,69 | 51,87 | +1,23% | 2,45% | 9.355.706 |
| 01/03/2018 | 51,77 | 52,30 | 50,97 | 51,24 | -0,96% | 2,56% | 13.648.523 |
| 28/02/2018 | 52,54 | 52,64 | 51,73 | 51,74 | -0,91% | 1,74% | 11.807.606 |
| 27/02/2018 | 53,35 | 53,40 | 52,19 | 52,21 | -2,39% | 2,25% | 9.734.453 |
| 26/02/2018 | 52,48 | 53,62 | 52,48 | 53,49 | +2,17% | 2,16% | 12.725.026 |
| 23/02/2018 | 52,31 | 52,48 | 52,07 | 52,36 | +0,55% | 0,78% | 9.499.177 |
| 22/02/2018 | 52,10 | 52,55 | 51,93 | 52,07 | +0,04% | 1,19% | 11.334.958 |
| 21/02/2018 | 52,51 | 52,90 | 52,05 | 52,05 | -0,78% | 1,62% | 11.244.935 |
| 20/02/2018 | 53,55 | 53,57 | 52,43 | 52,46 | -2,33% | 2,12% | 14.113.416 |
| 16/02/2018 | 53,41 | 54,38 | 53,36 | 53,71 | +0,54% | 1,91% | 12.294.402 |
| 15/02/2018 | 52,89 | 53,43 | 52,32 | 53,43 | +1,99% | 2,09% | 10.584.695 |
| 14/02/2018 | 51,82 | 52,58 | 51,74 | 52,39 | +0,00% | 1,62% | 11.996.142 |
| 13/02/2018 | 52,70 | 52,83 | 52,26 | 52,39 | -0,96% | 1,09% | 17.857.291 |
| 12/02/2018 | 52,81 | 53,33 | 52,44 | 52,89 | +1,02% | 1,68% | 13.259.506 |
| 09/02/2018 | 52,62 | 52,87 | 50,92 | 52,36 | +0,26% | 3,72% | 19.472.364 |
| 08/02/2018 | 53,47 | 53,87 | 52,20 | 52,22 | -2,06% | 3,12% | 21.871.760 |
| 07/02/2018 | 52,64 | 54,11 | 52,57 | 53,32 | +0,76% | 2,94% | 14.349.740 |
| 06/02/2018 | 52,61 | 54,17 | 51,84 | 52,92 | -1,67% | 4,43% | 32.494.498 |
| 05/02/2018 | 55,60 | 56,25 | 53,26 | 53,82 | -3,69% | 5,37% | 20.546.774 |
| 02/02/2018 | 56,69 | 57,22 | 55,61 | 55,88 | -2,17% | 2,84% | 12.852.777 |
| 01/02/2018 | 56,46 | 57,58 | 56,36 | 57,12 | +1,03% | 2,15% | 14.009.664 |